Association of beta-adrenoceptor polymorphisms with cardiac autonomic modulation in Japanese males.

[1]  K. Tsuda,et al.  Adrenergic receptor polymorphisms and autonomic nervous system function in human obesity , 2006, Trends in Endocrinology & Metabolism.

[2]  Bruce D. Johnson,et al.  Dietary sodium restriction and β2‐adrenergic receptor polymorphism modulate cardiovascular function in humans , 2006, The Journal of physiology.

[3]  Bruce D. Johnson,et al.  The Arg16Gly polymorphism of the β2‐adrenergic receptor and the natriuretic response to rapid saline infusion in humans , 2006, The Journal of physiology.

[4]  Zhaoqian Liu,et al.  β1‐Adrenergic receptor polymorphisms influence the response to metoprolol monotherapy in patients with essential hypertension , 2006 .

[5]  T. Lumley,et al.  &bgr;2-Adrenergic Receptor Genetic Variants and Risk of Sudden Cardiac Death , 2006 .

[6]  Bruce D. Johnson,et al.  Arg16Gly polymorphism of the β2‐adrenergic receptor is associated with differences in cardiovascular function at rest and during exercise in humans , 2006 .

[7]  H. Bruck,et al.  The Arg389Gly &bgr;1-adrenoceptor polymorphism does not affect cardiac effects of exercise after parasympathetic inhibition by atropine , 2006, Pharmacogenetics and genomics.

[8]  T. Ogihara,et al.  Beta2-adrenoceptor polymorphisms relate to insulin resistance and sympathetic overactivity as early markers of metabolic disease in nonobese, normotensive individuals. , 2005, American journal of hypertension.

[9]  T. Ogihara,et al.  β2- and β3-Adrenergic Receptor Polymorphisms Are Related to the Onset of Weight Gain and Blood Pressure Elevation Over 5 Years , 2005 .

[10]  K. Leineweber,et al.  Beta2-adrenoceptor gene polymorphisms. , 2005, Pharmacogenetics and genomics.

[11]  T. Moritani,et al.  Association of C825T polymorphism of G protein beta3 subunit with the autonomic nervous system in young healthy Japanese individuals. , 2005, American journal of hypertension.

[12]  Mark Daly,et al.  Haploview: analysis and visualization of LD and haplotype maps , 2005, Bioinform..

[13]  G. Willemsen,et al.  Heritability of Ambulatory Heart Rate Variability , 2004, Circulation.

[14]  S. Grandy,et al.  Overexpression of human β2-adrenergic receptors increases gain of excitation-contraction coupling in mouse ventricular myocytes , 2004 .

[15]  P. Insel,et al.  Autonomic Nervous System Pharmacogenomics: A Progress Report , 2004, Pharmacological Reviews.

[16]  M. Lohse.  β-Adrenoceptor polymorphisms and heart failure , 2004 .

[17]  H. Bruck,et al.  β-Adrenoceptor polymorphisms , 2003, Naunyn-Schmiedeberg's Archives of Pharmacology.

[18]  S. Liggett,et al.  Pharmacology and physiology of human adrenergic receptor polymorphisms. , 2003, Annual review of pharmacology and toxicology.

[19]  M. Leppert,et al.  The Arg16Gly polymorphism of the β2-adrenergic receptor and left ventricular systolic function☆ , 2003 .

[20]  T. Lumley,et al.  &bgr;2-Adrenergic Receptor Polymorphisms and Risk of Incident Cardiovascular Events in the Elderly , 2003, Circulation.

[21]  U. B. Nair,et al.  A common β1‐adrenergic receptor polymorphism (Arg389Gly) affects blood pressure response to β‐blockade , 2003 .

[22]  R. Maestri,et al.  Short-Term Heart Rate Variability Strongly Predicts Sudden Cardiac Death in Chronic Heart Failure Patients , 2003, Circulation.

[23]  E. Boerwinkle,et al.  β2‐Adrenergic receptor polymorphism and nitric oxide‐dependent forearm blood flow responses to isoproterenol in humans , 2003 .

[24]  K. Fong,et al.  Conservation of the cardiostimulant effects of (-)-norepinephrine across Ser49Gly and Gly389Arg beta(1)-adrenergic receptor polymorphisms in human right atrium in vitro. , 2002, Journal of the American College of Cardiology.

[25]  Sung-Hoon Kim,et al.  Significance of beta2-adrenergic receptor gene polymorphism in obesity and type 2 diabetes mellitus in Korean subjects. , 2002, Metabolism: clinical and experimental.

[26]  Kinga Howorka,et al.  Functional assessment of heart rate variability: physiological basis and practical applications. , 2002, International journal of cardiology.

[27]  R. Olshen,et al.  A polymorphism in the beta1 adrenergic receptor is associated with resting heart rate. , 2002, American journal of human genetics.

[28]  Dale R. Nyholt,et al.  Genetic case-control association studies – correcting for multiple testing , 2001, Human Genetics.

[29]  R. Kim,et al.  The effect of common polymorphisms of the beta2-adrenergic receptor on agonist-mediated vascular desensitization. , 2001, The New England journal of medicine.

[30]  R M Heethaar,et al.  Impaired autonomic function is associated with increased mortality, especially in subjects with diabetes, hypertension, or a history of cardiovascular disease: the Hoorn Study. , 2001, Diabetes care.

[31]  A. Dart,et al.  Cardiac Output In Mice Overexpressing β2‐Adrenoceptors Or With Myocardial Infarct , 2001, Clinical and experimental pharmacology & physiology.

[32]  R. Kim,et al.  Arg389Gly beta 1-adrenoceptor polymorphism varies in frequency among different ethnic groups but does not alter response in vivo. , 2001, Pharmacogenetics.

[33]  P. Insel,et al.  In-vivo studies do not support a major functional role for the Gly389Arg beta 1-adrenoceptor polymorphism in humans. , 2001, Pharmacogenetics.

[34]  R H Fagard,et al.  Relationships of heart rate and heart rate variability with conventional and ambulatory blood pressure in the population , 2001, Journal of hypertension.

[35]  A Malliani,et al.  Interpreting oscillations of muscle sympathetic nerve activity and heart rate variability , 2000, Journal of hypertension.

[36]  R S Judson,et al.  Complex promoter and coding region beta 2-adrenergic receptor haplotypes alter receptor expression and predict in vivo responsiveness. , 2000, Proceedings of the National Academy of Sciences of the United States of America.

[37]  R. Brook,et al.  Autonomic imbalance, hypertension, and cardiovascular risk. , 2000, American journal of hypertension.

[38]  M. Michel,et al.  Adrenergic and muscarinic receptors in the human heart. , 1999, Pharmacological reviews.

[39]  Jagmeet P. Singh,et al.  Reduced heart rate variability and new-onset hypertension: insights into pathogenesis of hypertension: the Framingham Heart Study. , 1998, Hypertension.

[40]  R W Barnes,et al.  Cardiac autonomic function and incident coronary heart disease: a population-based case-cohort study. The ARIC Study. Atherosclerosis Risk in Communities Study. , 1997, American journal of epidemiology.

[41]  T. Kuusela,et al.  The acute effects of inhaled salbutamol on the beat-to-beat variability of heart rate and blood pressure assessed by spectral analysis. , 1997, British journal of clinical pharmacology.

[42]  J. Cai,et al.  Association of cardiac autonomic function and the development of hypertension: the ARIC study. , 1996, American journal of hypertension.

[43]  G. Piccirillo,et al.  Heart rate variability in hypertensive subjects. , 1996, International journal of cardiology.

[44]  G. Breithardt,et al.  Heart rate variability: standards of measurement, physiological interpretation and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology. , 1996 .

[45]  D. Eckberg,et al.  Important influence of respiration on human R-R interval power spectra is largely ignored. , 1993, Journal of applied physiology.

[46]  R. Cohen,et al.  Power spectrum analysis of heart rate fluctuation: a quantitative probe of beat-to-beat cardiovascular control. , 1981, Science.